MARKET

EXAS

EXAS

EXACT Sci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

118.47
+0.44
+0.37%
Opening 12:47 07/23 EDT
OPEN
118.64
PREV CLOSE
118.03
HIGH
118.72
LOW
114.93
VOLUME
286.18K
TURNOVER
--
52 WEEK HIGH
159.54
52 WEEK LOW
70.75
MARKET CAP
20.32B
P/E (TTM)
-23.6217
1D
5D
1M
3M
1Y
5Y
Calamos Wealth Management Llc Buys Eli Lilly and Co, Carrier Global Corp, Aptiv PLC, Sells ...
GuruFocus News · 1d ago
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Should You Buy?
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 1d ago
Albireo (ALBO) Gets FDA Nod for Rare Liver Disease Drug
Zacks.com · 2d ago
Cathie Wood's ARK Innovation rises amid market plunge — here's what's working in her fund
Concerns about the Delta variant and another round of economic shutdowns could be scaring investors back into Wood's pandemic-proof stocks.
CNBC.com · 3d ago
Exact Sciences, Vericel Corp, Home Depot, ExxonMobil and Discover Financial Services highlighted as Zacks Bull and Bear of the Day
Zacks.com · 4d ago
Bull of the Day: Exact Sciences (EXAS)
Zacks.com · 4d ago
Cassava Sciences (SAVA) to Post Q2 Earnings: What's in Store?
Zacks.com · 6d ago
Synlogic's (SYBX) Begins Phase I Study for PKU Treatment
Zacks.com · 07/16 15:22
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EXAS. Analyze the recent business situations of EXACT Sci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EXAS stock price target is 156.94 with a high estimate of 185.00 and a low estimate of 120.00.
EPS
Institutional Holdings
Institutions: 866
Institutional Holdings: 167.91M
% Owned: 97.88%
Shares Outstanding: 171.55M
TypeInstitutionsShares
Increased
254
18.84M
New
96
2.85M
Decreased
172
12.93M
Sold Out
70
1.97M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
+0.79%
Key Executives
Chairman/President/Chief Executive Officer/Director
Kevin Conroy
Chief Financial Officer/Chief Operating Officer/Executive Vice President
Jeffrey Elliott
Senior Vice President/Chief Administrative Officer/General Counsel/Secretary
D. Scott Coward
Senior Vice President
Ana Hooker
Chief Scientific Officer
Graham Lidgard
General Manager
Jake Orville
General Manager
Gisela Paulsen
Independent Director
James Doyle
Independent Director
Pierre Jacquet
Independent Director
Daniel Levangie
Independent Director
Freda Lewis-Hall
Independent Director
Shacey Petrovic
Independent Director
Kathleen Sebelius
Independent Director
Katherine Zanotti
No Data
About EXAS
Exact Sciences Corporation is a cancer screening and diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) scan.

Webull offers kinds of EXACT Sciences Corporation stock information, including NASDAQ:EXAS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EXAS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EXAS stock methods without spending real money on the virtual paper trading platform.